Development of targeted therapies in advanced gastric cancer: promising exploratory steps in a new era.

Wagner, Anna D; Moehler, Markus

Wagner, Anna D; Moehler, Markus.

Affiliation

Wagner AD; Multidisciplinary Oncology Center, Lausanne University Hospital, Lausanne, Switzerland. dorothea.wagner@chuv.ch

Curr Opin Oncol ; 21(4): 381-5, 2009 Jul.

Article in En | MEDLINE | ID: mdl-19412098

Subject(s)

Stomach Neoplasms/drug therapy; Angiogenesis Inhibitors/therapeutic use; Clinical Trials, Phase III as Topic; Drug Delivery Systems; ErbB Receptors/antagonists & inhibitors; Humans; Neovascularization, Pathologic/drug therapy; Protein Kinase Inhibitors/therapeutic use; Randomized Controlled Trials as Topic; Receptor, ErbB-2/antagonists & inhibitors; Stomach Neoplasms/blood supply; Stomach Neoplasms/enzymology

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Stomach Neoplasms Type of study: Clinical_trials / Prognostic_studies Limits: Humans Language: En Journal: Curr Opin Oncol Journal subject: NEOPLASIAS Year: 2009 Type: Article Affiliation country: Switzerland

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google